简介:
Overview
This innovative device uses magneto-inertial sensors to permit gait and activity analysis in uncontrolled environments. It is currently in the qualification process as an outcome measure in the European Medical Agency.
Key Study Components
Area of Science
- Neuroscience
- Clinical Trials
- Neuromuscular Diseases
Background
- The device captures movements using dedicated algorithms.
- It allows for objective assessment of both ambulant and non-ambulant subjects.
- Initially developed for neuromuscular patients, it has broader applications.
- Visual demonstrations aid in understanding device setup.
Purpose of Study
- To measure activity in neuromuscular patients.
- To serve as a clinical endpoint in clinical trials.
- To provide a continuous in-home-based activity measurement.
Methods Used
- Use of magneto-inertial sensors.
- Dedicated algorithms for movement capture.
- Exploratory outcome measures in clinical trials.
- Visual demonstrations for setup guidance.
Main Results
- Objective assessment of motor activity.
- Broad applicability for various pathologies.
- Effective in both controlled and uncontrolled environments.
- Supports clinical trials for neuromuscular and neurologic diseases.
Conclusions
- The device enhances gait and activity analysis.
- It is a promising tool for clinical endpoints in trials.
- Continued development is essential for broader applications.
What is the main function of the device?
The device analyzes gait and activity using magneto-inertial sensors.
Who can benefit from this device?
Patients with neuromuscular diseases and other movement disorders.
How does the device improve clinical trials?
It serves as an objective outcome measure for assessing motor activity.
What technology does the device use?
It utilizes magneto-inertial sensors and dedicated algorithms.
Is the device suitable for home use?
Yes, it is designed for continuous in-home-based activity measurement.
What are the next steps for the device?
It is currently undergoing qualification by the European Medical Agency.